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Abstract
The transcription factor Gli3 is important for brain and limb development. Mice homozygous for a
mutation in Gli3 (Gli3Xt/Xt) have severe abnormalities of telencephalic development and previous
studies have suggested that aberrant cell death may contribute to the Gli3Xt/Xt phenotype. We
demonstrate that telencephalic cells from embryonic Gli3Xt/Xt embryos survive better and are
more resistant to death induced by cytosine arabinoside, a nucleoside analogue that induces death
in neuronal progenitors and neurons, than are control counterparts in vitro. Culture medium
conditioned by Gli3Xt/Xt cells is more effective at enhancing the viability of control telencephalic
cells than medium conditioned by control cells, indicating that Gli3Xt/Xt cells release a factor or
factors which enhance telencephalic cell viability. Gli3Xt/Xt cells are also more sensitive to
released factors present in conditioned media. These data suggest that Gli3 plays both cell-
autonomous and cell-nonautonomous roles in mediating telencephalic cell viability.
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Introduction
Gli genes encode zinc-finger transcription factors homologous to the Drosophila segment
polarity gene cubitus interruptus (Ingham & McMahon, 2001). Gli3Xt/Xt mice die perinatally
with many brain abnormalities (Johnson, 1967; Hui & Joyner, 1993). Structures in the dorsal
telencephalon are particularly affected: cortical lamination is disrupted and midline
structures, such as the hippocampus, are absent (Hui & Joyner, 1993; Franz, 1994; Grove et
al., 1998; Theil et al., 1999; Tole et al., 2000). Little is known about the mechanisms
underlying this severe telencephalic phenotype but one process that may be disrupted is
programmed cell death (PCD). There is a reduced frequency of apoptotic cells in the
Gli3Xt/Xt forebrain (Aoto et al., 2002) and mice with mutations in the genes encoding
essential components in the mammalian PCD pathway display similar CNS abnormalities to
those seen in Gli3Xt/Xt embryos. These similarities include cerebral cortical heterotopias and
partially penetrant exencephaly (Grove et al., 1998; Hakem et al., 1998; Kuida et al., 1998;
Theil et al., 1999; Tole et al., 2000). It is probable therefore that the defects in PCD in the
Gli3Xt/Xt telencephalon contribute significantly to its structural defects. Our aims were to
test whether increased viability is an intrinsic property of Gli3Xt/Xt telencephalic cells and
whether this is achieved though changes in cell-cell signalling.
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Materials and methods
Gli3 expression
We examined the expression of Gli3 using in situ hybridization (Nieto et al., 1996). A 449-
bp fragment (nucleotides 4585-5033 of the mouse Gli3 cDNA) was PCR-amplified,
subcloned and used to generate digoxigenin-labelled RNA antisense probes. For Western
blot analysis, protein lysates were prepared from embryonic day (E)14.5 dorsal and ventral
telencephalon and run on NuPAGE 3-8% Tris-Acetate gels (Invitrogen, UK). Blots were
incubated with a rabbit polyclonal anti-Gli3 antibody (Santa Cruz Biotechnology, USA; 1:
100).
Cultures
Gli3Xt/+ mice (the mutant allele is XtJ; Hui & Joyner, 1993) on a CBA background were
interbred. All animals were treated in accordance with the UK Animal Scientific Procedures
Act (1986). Animals were killed by cervical dislocation. The morning of vaginal plug was
designated E0.5. Gli3Xt/Xt embryos were easily identified by their severe polydactyly and
abnormal head morphology (Hui & Joyner, 1993); exencephalic embryos were excluded.
Previous studies found no differences in forebrain morphology nor in patterns of gene
expression between wild-type and Gli3Xt/+ E12.5-15.5 brains (Tole et al., 2000; our
unpublished observations). We found no differences in cell viability or proportions of
different cell types in telencephalic cultures from wild-type and Gli3Xt/+ E15.5 brains. At
E14.5 therefore, where the presence of an extra digit in heterozygotes could not be assessed
reliably, embryos that were not Gli3Xt/Xt were pooled and used as the source of ‘control’
cells. Dorsal and ventral telencephalon were isolated: ventral tissue included the lateral and
medial ganglionic eminences. Cells were dissociated by incubation for 45 min at 37 °C with
papain (20 units/mL; Papain Dissociation System, Worthington Biochemical, UK). Cells in
suspension were either plated for cell death experiments and immunocytochemistry or fixed
for flow cytometry.
Cell death experiments
Dissociated cells were plated on poly L-lysine at 1000 cells/mm2 in a volume of 200 μL and
cultured for 24 h at 37 °C in defined serum-free medium. In some experiments, cells were
treated with 100 μM cytosine arabinoside (AraC) (Sigma, UK) for the final 6 h of the 24-h
culture period. For conditioned medium experiments, cells were plated at 1000 cells/mm2
and allowed to settle for 2 h; 150 μL of medium was then replaced with medium from wells
in which cells had been grown for 24 h at 1000-16 000 cells/mm2. Experiments were
terminated after either 24 or 48 h.
Cells were fixed with 4% paraformaldehyde containing Hoescht 33342 (Sigma). Healthy
and dead cells were distinguished by nuclear morphology (Kerr et al., 1972). Dying and
dead cells showed dense chomatin condensation, some of which had fragmented into
apoptotic bodies, and were immunoreactive for active caspase-3 (our unpublished
observations). Data from wild-type and Gli3Xt/+ cells were pooled and presented as
‘control’. At least three fields of view were counted from two or three wells of each
condition. Significant differences in viability were established with Student’s t-test or an
ANOVA by Univariate General Linear Model.
BrdU labelling
Dissociated cells were treated with 10 μM bromodeoxyuridine (BrdU) for the 24-h culture
period. BrdU was detected using mouse anti-BrdU (Becton Dickenson, USA; 1 : 200) and
goat antimouse Alexa 488 (Molecular Probes, USA; 1 : 200).
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Flow cytometry
Dissociated telencephalic cells were fixed in ice-cold 70% ethanol and 5-10 × 105 cells were
incubated with primary antibodies: mouse antimicrotubule-associated protein 2 (MAP2;
Sigma; 1 : 800) and antiproliferating cell nuclear antigen (PCNA; Dako, UK; 1 : 200).
Primary antibodies were detected with goat antimouse Alexa 488 (Molecular Probes; 1 :
400). Cellular DNA was then stoichiometrically stained by incubation with propidium
iodide (PI, Molecular Probes) at 50 μg/mL with RNAse A at 125 μg/mL at 37°C for 30 min.
Cells were analysed on a Beckman-Coulter XL flow cytometer. 10 000-20 000 cells were
analysed per sample. Single cells were gated away from clumps by pulse height-width
analysis of the DNA signal generated by the fluorescence of DNA-bound PI, measured in
the FL3 channel. Fluorescence intensity of bound secondary antibody was measured in the
FL1 channel.
Results
In situ hybridization showed that Gli3 is normally expressed in both dorsal and ventral
telencephalon at E14.5 (Fig. 1A; Hui et al., 1994). Western blots confirmed that Gli3 protein
is produced in both these regions (Fig. 1B). The viabilities of cultured E14.5-15.5 Gli3Xt/Xt
dorsal and ventral telencephalic cells were significantly higher than the viabilities of
corresponding control cells (Fig. 1C).
An important consideration in interpreting this increased viability was evidence that rates of
PCD in normally developing cortex are higher in the proliferating population than among
differentiating cells (Thomaidou et al., 1997). If Gli3Xt/Xt telencephalon has an abnormally
low proportion of proliferating cells, this might account for its enhanced viability in culture.
To examine this possibility, dissociated cells were prepared for flow cytometry using
antibodies for PCNA, a marker of cycling cells (Fig. 2A-C), and MAP2, a marker of
postmitotic neurons (Fig. 2D-F). A threshold that included only 0.1% of cells during control
runs (Fig. 2A and D) was maintained in experimental runs (Fig. 2B, C, E and F). The
proportions of cells whose fluorescence intensities exceeded this threshold were counted.
For MAP2 (Fig. 2D-F), the gate was set to exclude a small fraction with a higher-than-
diploid DNA content (i.e. those undergoing replication) that expressed a low level of MAP2.
No expression of MAP2 was detected among cells from non-neural tissue, whether they had
a diploid or a higher DNA content (data not shown), indicating that enhanced fluorescence
of telencephalic cells stained with MAP2, even those that were proliferating, was due to
specific staining.
There were no significant differences between control and Gli3Xt/Xt dorsal or ventral
telencephalon in the proportions of cells labelled with PCNA or MAP2 at either E14.5 or
E15.5 (Fig. 2G and H). Similar results were obtained when dissociated cells were plated,
stained with antibodies recognizing MAP2 and the neural progenitor markers RC2 and
nestin, and quantified (our unpublished observations).
In some experiments on E14.5 telencephalic cells, BrdU was included in the medium for the
entire culture period. The proportions of BrdU-labelled cells were similar in all cultures
(mean ± SEM, 12.8 ± 1.0% for control dorsal telencephalon, 10.4 ± 2.4% for Gli3Xt/Xt
dorsal telencephalon, 9.4 ± 2.3% for control ventral telencephalon and 12.6 ± 9.8% for
Gli3Xt/Xt ventral telencephalon). From these and the preceding experiments, we concluded
that there were no major differences in the proportions of proliferating and differentiated
cells between control and Gli3Xt/Xt cultures.
Further evidence that increased viability in Gli3Xt/Xt cultures most probably reflects a
difference in the properties of the mutant cells came from an analysis of the effect of the
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nucleoside analogue AraC, which induces apoptosis in neural progenitors and neurons
(D’Sa-Eipper & Roth, 2000; Geller et al., 2001). The viability of E15.5 dorsal and ventral
telencephalic control cells was significantly reduced by treatment with AraC to 73 ± 3%
(dorsal cells; P = 0.035, Student’s t-test, n = 4) and 88 ± 6% (ventral cells; P = 0.045, n = 4)
of the survival of untreated cells. AraC treatment did not significantly decrease the viability
of Gli3Xt/Xt ventral telencephalic cells (95 ± 3% of the survival of untreated cells, n = 4).
Although the viability of Gli3Xt/Xt dorsal telencephalic cells was decreased to 89 ± 2% of
the survival in untreated control cultures after AraC treatment (P = 0.025, n = 4), this
decrease was significantly smaller than that induced in control dorsal telencephalic cells (P =
0.002, n = 4). We conclude that Gli3Xt/Xt dorsal and ventral telencephalic cells are more
resistant to AraC than are corresponding control cells.
To test the possibility that Gli3Xt/Xt telencephalic cells release more and/or more potent
survival-promoting factors than control cells, we carried out conditioned medium
experiments. Medium from cultures of control or Gli3Xt/Xt dorsal telencephalic cells at
densities from 1000 to 16 000 cells/mm2 was added to control dorsal telencephalic cells.
The viability of the test cells after 24 h was related to the density of cells used to condition
the media, regardless of the genotype of the conditioning cells (Fig. 3A; P = 0.013, ANOVA by
Univariate General Linear Model, n = 11). In addition, Gli3Xt/Xt-conditioned medium had a
significantly greater effect on viability than control-conditioned medium (Fig. 3A; P =
0.029, ANOVA by Univariate General Linear Model, n = 11). This was clearer when cultures
containing conditioned medium were compared after 48 h (Fig. 3B). In these experiments,
conditioned medium was from control or Gli3Xt/Xt dorsal or ventral telencephalic cells (at
12 000 cells/mm2). Similar to cultures grown for 24 h, viabilities of Gli3Xt/Xt dorsal and
ventral telencephalic cells grown for 48 h (without any conditioned medium added) were
significantly higher than those of corresponding control cells (solid bars in Fig. 3B). The
viabilities of control and Gli3Xt/Xt dorsal and ventral telencephalic cells treated with
Gli3Xt/Xt-conditioned medium were significantly higher than the viabilities of these cells
treated with control-conditioned medium (Fig. 3B). Additionally, dorsal and ventral
telencephalic Gli3Xt/Xt cells, unlike control cells, had their viability enhanced by treatment
with conditioned medium from control cells (Fig. 3B). This suggests that Gli3Xt/Xt cells (i)
release more and/or more potent survival-promoting factors than control telencephalic cells,
and (ii) Gli3Xt/Xt telencephalic cells are more sensitive than control cells to such factors.
Discussion
Our results indicate that the increased viability of Gli3Xt/Xt telencephalic cells is an intrinsic
property of these cells. This property results from changes in both the production of
viability-enhancing factor(s) by the mutant cells (a cell-nonautonomous mechanism) and the
responsiveness of mutant cells to such factors (a cell-autonomous mechanism). The viability
of cells in both the dorsal and the ventral telencephalon are affected to a similar degree.
Although Gli3 is expressed both dorsally and ventrally, previous work has shown that the
morphological defects in the telencephalon of Gli3Xt/Xt embryos are more severe dorsally
(Theil et al., 1999; Tole et al., 2000). Interestingly, decreased PCD in mice mutant for
caspase-3 or caspase-9 also results in more severe defects in the dorsal telencephalon (Kuida
et al., 1996, 1998; Hakem et al., 1998). The organization of the dorsal telencephalon might
be more sensitive to changes in PCD than other areas of the telencephalon, although
additional cellular defects probably contribute to the phenotype of Gli3Xt/Xt embryos.
Similarities between the consequences of Gli3 deficiency and reduced PCD in embryos
extend to other Gli3-expressing structures. Like Gli3Xt/Xt embryos (Theil et al., 1999; Franz
& Besecke, 1991; Hui & Joyner, 1993; Tole et al., 2000), mice mutant in caspase-9 (Kuida
et al., 1998) or apoptotic protease-activating factor (Cecconi et al., 1998; Yoshida et al.,
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1998; Honarpour et al., 2000) display persistence of interdigital webbing and defects in
neural tube closure and in eye and lens development. The molecular mechanisms by which
Gli3 influences PCD are unknown; our results suggest that altered secretion of and
sensitivity to molecules involved in controlling PCD are likely to be involved.
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Fig. 1.
(A) In situ hybridization for Gli3 at E14.5: DT, dorsal telencephalon; VT, ventral
telencephalon. (B) Both full-length and cleaved forms of the Gli3 protein are present in
E14.5 DT and VT. Bands corresponding to these isoforms are absent from Gli3Xt/Xt tissue.
(C) Mean + SEM viabilities of cells from DT and VT of control and Gli3Xt/Xt embryos:
significant differences are marked (*P< 0.01; Student’s paired t-tests, n = 7-14).
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Fig. 2.
Representative examples of flow cytometry: (A-C) PCNA and (D-F) MAP2 staining on
E15.5 control and Gli3Xt/Xt dorsal telencephalon (DT). Antibody staining intensity
(FL1LOG on a log scale) is plotted against DNA content (FL3LIN on a linear scale). Gate B
was set to include (A-C) cells expressing a high level of PCNA or (D-F) cells expressing a
high level of MAP2 with a diploid DNA content. (G,H) There were no differences between
proportions of PCNA- and MAP2-immunopositive cells in samples from control and
Gli3Xt/Xt embryos in either the DT or ventral telencephalon (VT) (means of 2-4 experiments
are shown).
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Fig. 3.
(A) Viability of control dorsal telencephalic cells cultured for 24 h with conditioned medium
(CM) plotted against the density of the cells used to produce the CM (1,000-16 000 cells/
mm2). Viability was affected significantly by the density of the conditioning cells and by
their genotype. (B) Mean viabilities (+ SEM) of Gli3Xt/Xt dorsal telencephalic (DT) and
ventral telencephalic (VT) cells grown for 48 h in control medium or CM. Significant
differences are marked (*P< 0.05, Student’s t-test, n = 4-7).
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